에이치엘비바이오스텝(주)

{
  "address": "인천 연수구",
  "ceo_name": "백성진",
  "certificate": [
    {
      "cert_number": "20130102438",
      "changes": "",
      "disclosure_date": "2013-04-02",
      "first_cert_date": "2013-04-02",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2013-04-02 ~ 2015-04-01"
    },
    {
      "cert_number": "20150103764",
      "changes": "",
      "disclosure_date": "2015-04-29",
      "first_cert_date": "2013-04-02",
      "no": "2",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2015-04-02 ~ 2017-04-01"
    },
    {
      "cert_number": "20170103996",
      "changes": "",
      "disclosure_date": "2017-04-21",
      "first_cert_date": "2013-04-02",
      "no": "3",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2017-04-02 ~ 2019-04-01"
    },
    {
      "cert_number": "20190102587",
      "changes": "",
      "disclosure_date": "2019-03-26",
      "first_cert_date": "2013-04-02",
      "no": "4",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2019-04-02 ~ 2021-04-01"
    },
    {
      "cert_number": "20210507030005",
      "changes": "",
      "disclosure_date": "2021-05-07",
      "first_cert_date": "2013-04-02",
      "no": "5",
      "type": "혁신성장유형",
      "valid_period": "2021-04-02 ~ 2024-04-01"
    },
    {
      "cert_number": "20240626030087",
      "changes": "대표자",
      "disclosure_date": "2024-06-26",
      "first_cert_date": "2013-04-02",
      "no": "6",
      "type": "혁신성장유형",
      "valid_period": "2024-06-26 ~ 2027-06-25"
    }
  ],
  "company_name": "에이치엘비바이오스텝 주식회사 (HLB bioStep Co., Ltd.)",
  "corp_no": "284211-*******",
  "financials": {
    "2022": {
      "capital_stock": 7053033000,
      "cost_of_sales": 8893012000,
      "current_assets": 107187664000,
      "current_liabilities": 9364300000,
      "gross_profit": 47743150000,
      "net_income": -3032420000,
      "net_income_bs": -3360461000,
      "non_current_assets": 54111133000,
      "non_current_liabilities": 86212716000,
      "non_operating_expenses": 11736338000,
      "non_operating_income": 3100493000,
      "operating_profit": 5603425000,
      "revenue": 56636162000,
      "sga_expenses": 42139726000,
      "total_assets": 161298796000,
      "total_equity": 65721780000,
      "total_liabilities": 95577016000
    },
    "2023": {
      "capital_stock": 7863390000,
      "cost_of_sales": 225032000,
      "current_assets": 74127020000,
      "current_liabilities": 61527620000,
      "gross_profit": 33391296000,
      "net_income": -59995000,
      "net_income_bs": -333701000,
      "non_current_assets": 88736115000,
      "non_current_liabilities": 2403380000,
      "non_operating_expenses": 4062379000,
      "non_operating_income": 5735795000,
      "operating_profit": -1733411000,
      "revenue": 33616328000,
      "sga_expenses": 35124708000,
      "total_assets": 162863136000,
      "total_equity": 98932136000,
      "total_liabilities": 63931000000
    }
  },
  "industry": "물리, 화학 및 생물학 연구개발업",
  "investment": [],
  "main_products": "비임상실험유효성(약리) 평가,실험동물 연구대행",
  "phone": "032-833-****",
  "years": [
    2023,
    2022
  ]
}